journal cover

Long-term treatment of venous thromboembolism

Blood

Jan 10, 2020

Clive Kearon, Susan R Kahn

Abstract

The most important decision in the long-term treatment of VTE is how long to anticoagulate. VTE provoked by a reversible risk factor, or a first unprovoked isolated distal DVT, generally should be treated for 3 months. VTE provoked by a persistent or progressive risk factor (eg, cancer)...read more

Mentioned in this Paper

Barrett Esophagus-Indefinite for Dysplasia
Lesion
Anticoagulation Therapy
Long-term Care
Antiphospholipid Antibodies
Explanation of Plan: Medication
Malignant Neoplasms
Medical Contraindication
Pulmonary Embolism
Chronic Thromboembolic Pulmonary Hypertension
43
1
Paper Details
References
  • References65
  • Citations
12345...
  • References65
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.

Similar Papers Found In These Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Chronic Thromboembolic Pulmonary Hypertension

Chronic thromboembolic pulmonary hypertension refers to high blood pressure in arteries of the lung. The underlying cause include blood clots and related scarring. Discover the latest research on this disease here.

Embolic Disease

Embolic diseases can result in serious complications, depending where the emboli travels and organs that it affects. Thromboembolisms arise from pieces of a blood clot breaking free. Treatment and prevention involves anticoagulants for the different types of embolic diseases. Here is the latest research on embolic diseases.

Deep Vein Thrombosis

Deep vein thrombosis (DVT) can be a serious life-threatening condition if not treated. DVT results from a clot forming in one of the deep veins, usually in the lower leg. If the clot breaks free it can lead to a pulmonary embolism and/or post-thrombotic syndrome. Here is the latest research on DVT.

Related Papers

Journal of Thrombosis and Thrombolysis

Duration of anticoagulation for venous thromboembolism

Journal of Thrombosis and ThrombolysisNovember 17, 2001
Clive Kearon
© 2020 Meta ULC. All rights reserved

Long-term treatment of venous thromboembolism

Blood

Jan 10, 2020

Clive Kearon, Susan R Kahn

PMID: 31917402

DOI: 10.1182/blood.2019002364

Abstract

The most important decision in the long-term treatment of VTE is how long to anticoagulate. VTE provoked by a reversible risk factor, or a first unprovoked isolated distal DVT, generally should be treated for 3 months. VTE provoked by a persistent or progressive risk factor (eg, cancer)...read more

Mentioned in this Paper

Barrett Esophagus-Indefinite for Dysplasia
Lesion
Anticoagulation Therapy
Long-term Care
Antiphospholipid Antibodies
Explanation of Plan: Medication
Malignant Neoplasms
Medical Contraindication
Pulmonary Embolism
Chronic Thromboembolic Pulmonary Hypertension
43
1

Similar Papers Found In These Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Chronic Thromboembolic Pulmonary Hypertension

Chronic thromboembolic pulmonary hypertension refers to high blood pressure in arteries of the lung. The underlying cause include blood clots and related scarring. Discover the latest research on this disease here.

Related Papers

Journal of Thrombosis and Thrombolysis

Duration of anticoagulation for venous thromboembolism

Journal of Thrombosis and ThrombolysisNovember 17, 2001
Clive Kearon
Paper Details
References
  • References65
  • Citations
12345...
  • References65
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.
/papers/long-term-treatment-of-venous-thromboembolism/31917402